In vitro and in vivo TNFα synthesis modulation by methylguanidine, an uremic catabolyte
- 6 August 1999
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 65 (11), PL121-PL127
- https://doi.org/10.1016/s0024-3205(99)00355-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Reduction of Mononuclear Cytokine Production in Hemodialysis Patients Treated with Steam-Sterilized Low-Flux Polysulphone MembranesThe International Journal of Artificial Organs, 1998
- Macrophage colony stimulating factor involvement in uremic patientsKidney International, 1996
- The immune effects of neuropeptidesBailliere's Clinical Rheumatology, 1996
- Effect of methylguanidine on rat blood pressure: role of endothelial nitric oxide synthaseBritish Journal of Pharmacology, 1995
- Production of interleukin-6, tumor necrosis factor α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patientsKidney International, 1995
- Cellular Immunity in Hemodialysis Patients: A Quantitative Analysis of Immune Cell Subsets by Flow CytometryAmerican Journal of Nephrology, 1995
- Parathyroid Hormone and the Cellular Immune SystemNephron, 1995
- T Cell Function in Chronic Renal Failure and DialysisBlood Purification, 1994
- The immune system in end-stage renal diseaseCurrent Opinion in Nephrology and Hypertension, 1993
- Production of Methylguanidine from Creatinine in Normal Rats and Rats with Renal FailureNephron, 1990